Hypertension and dementia

Current Hypertension Reports

Volumn 3, Issue 6, 2001, Pages 454-457

  Rigaud, Anne Sophie ^a   Hanon, Olivier ^a   Seux, Marie Laure ^a   Forette, Françoise ^a  

^a Paris Descartes University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

DEMENTIA; HUMAN; HYPERTENSION; HYPOTENSION; LONGITUDINAL STUDY; MULTIINFARCT DEMENTIA; REVIEW; RISK FACTOR;

ANTIHYPERTENSIVE AGENTS; DEMENTIA; DEMENTIA, VASCULAR; HUMAN; HYPERTENSION; HYPOTENSION; LONGITUDINAL STUDIES; RISK FACTORS;

EID: 0035653693     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-001-0005-y     Document Type: Article

References (43)

1. Seux ML, Thijs L, Forette F., et al.: Correlates of cognitive status of old patients with isolated systolic hypertension: the Syst-Eur Vascular Dementia Project. J Hypertens 1998, 16:963-969.
2. Breteler MMB, Grobbee DE, Hofman A: Blood pressure, hypertension, orthostatic hypotension, and cognitive function in the elderly. The Rotterdam Study. In Cognitive Decline in the Elderly. Epidemiologic Studies on Cognitive Function and Dementia. Thesis. Edited by: Breteler MMB. Rotterdam: Erasmus University; 1993:60-67.
3. Launer J, Masaki K, Petrovitch H., et al.: The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995, 274:1846-1851.
4. Guo Z, Fratiglioni L, Winblad B., Viitanen M: Blood pressure and performance on the Mini-Mental State Examination in the very old. Am J Epidemiol 1997, 145:1106-1113.
5. Guo Z, Viitanen M, Fratiglioni L., Winblad B: Low blood pressure and dementia in elderly people: The Kungsholmen Project. BMJ 1996, 312: 805-808.
6. Elias PK, D'Agostino RB, Elias MF, Wolf PA: Blood pressure, hypertension, and age as risk factors for poor cognitive performance. Exp Aging Res 1995, 21: 393-417.
7. Kilander L: Cognitive Dysfunction in the Elderly. The Implication of Cerebrovascular Risk Factors. Uppsala, Sweden: Acta Universitatis Upsaliensis; 1997.
8. Okumiya K, Matsubayashi K, Wada T., et al.: J-curve relation between blood pressure and decline in cognitive function in older people living in community, Japan. J Am Geriatr Soc 1997, 45:1032-1033.
9. Zhu L, Viitanen M, Guo Z., et al.: Blood pressure reduction, cardiovascular diseases and cognitive decline in the Mini-Mental State Examination in a community population of normal very old people: a three-year follow-up. J Clin Epidemiol 1998, 51:385-391.
10. Glynn RJ, Beckett LA, Hebert L.E., et al.: Current and remote blood pressure and cognitive decline. JAMA 1999, 281:438-445.
11. Skoog I, Lernfelt B, Landahl S., et al.: A 15-year longitudinal study of blood pressure and dementia. Lancet 1996, 347:1141-1145.
12. Guo Z, Fratiglioni L, Zhu L., et al.: Occurrence and progression of dementia in a community population aged 75 years and older. Relationship of antihypertensive medication use. Arch Neurol 1999, 65:991-996.
13. Strandgaard S, Paulson OB: Cerebrovascular consequences of hypertension. Lancet 1994, 344:519-520.
14. Breteler MMB, van Swieten JC, Bots ML, et al.: Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam study. Neurology 1994, 44:1246-1252.
15. Skoog I: A review on blood pressure and ischaemic white matter lesions. Dement Geriatr Cogn Disord 1998, 9(SUPPL. 1):13-19.
16. World Health Organization: The ICD 10 classification of mental and behavioral disorders. Diagnostic criteria for research. Geneva: World Health Organization; 1993.
17. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th edn. Washington, DC: APA; 1994.
18. Lindsay J, Hebert R, Rockwood K: The Canadian study of health and aging-risk factors for vascular dementia. Stroke 1997, 28:526-530.
19. Skoog I: Status of risk factors for vascular dementia. Neuroepidemiology 1998, 17:2-9.
20. Mckhann G, Drachman D, Folstein M., et al.: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer disease. Neurology 1984, 34:939-944.
21. Prince MJ, Cullen MC, Mann AH: Risk factors for Alzheimer's disease and dementia: a case control study based on the MRC elderly hypertension trial. Neurology 1994, 4:97-104.
22. Kokmen E, Beard CM, Chandra V, et al: Clinical risk factors for Alzheimer's disease: a population-based case-control study. Neurology 1991, 41:1393-1397.
23. Landin K, Blennow K, Wallin A., Gottfries C: Low blood pressure and blood glucose levels in Alzheimer's disease: Evidence for a hypometabolic disorder? J Intern Med 1993, 233:367-362.
24. Di Ioro A., Zito M, Abate G: Are vascular factors involved in Alzheimer's disease? Facts and theories. Aging Clin Exp Res 1999, 11:345-352.
25. Kokmen E, Whisnant JP, O'Fallon WM, et al: Dementia after ischemic stroke. A population based study in Rochester, Minnesota (1960-1984). Neurology 1996, 46:154-159.
26. Henon H, Pasquier F, Durieu I., et al.: Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. Stroke 1997, 28:2429-2436.
27. Prince MJ, Bird AS, Blizard R.A., Mann AH: Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults. BMJ 1996, 312:801-805.
28. Applegate WB, Pressel S, Wittes J., et al.: Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the Systolic Hypertension in the Elderly Program. Arch Intern Med 1994, 154:2154-2160.
29. Di Bari M., Pahor M, Franse L.V., et al.: Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. Am J Epidemiol 2001, 153:72-78.
30. Guo Z, Fratiglioni L, Zhu L., et al.: Occurrence and progression of dementia in a community population aged 75 years and older. Relationship of antihypertensive medication use. Arch Neurol 1999, 65:991-996.
31. Starr JM, Whalley LJ, Deary IJ: The effects of antihypertensive treatment on cognitive function: results from the HOPE study. J Am Geriatr Soc 1996, 44:411-415.
32. Cervilla JA, Prince M, Joels S., et al.: Long-term predictors of cognitive outcome in a cohort of older people with hypertension. Br J Psychiatry 2000, 177:66-71.
33. Tzourio C, Dufouil C, Ducimetière P, Alpérovitch A, for the EVA Study Group: Cognitive decline in individuals with high blood pressure. Neurology 1999, 53:1948-1952.
34. Heckbert SR, Longstreth WT, Psaty B.M., et al.: The association of antihypertensive agents with MRI white matter findings and with modified Mini-Mental State Examination in older adults. J Am Geriatr Soc 1997, 45:1423-1433.
35. Maxwell CJ, Hogan DB, Ebly EM: Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging. Can Med Assoc J 1999, 161:501-506.
36. MRC Working Party: Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992, 304:405-412.
37. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255-3264.
38. Staessen JA, Fagard R, Thijs L., et al, for the Systolic Hypertension in Europe (Syst-Eur) Trial investigators: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997, 350:757-764.
39. Forette F, Seux ML, Staessen J.A., et al.: Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998, 352:1347-1351.
40. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental Test,". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
41. Morich FJ, Bieber F, Lewis JM: Nimodipine in the treatment of probable Alzheimer's disease: results of two multicentre trials. Clin Drug Invest 1996, 11:185-195.
42. Parneti L, Senin U, Mecocci P: Cognitive enhancement therapy for Alzheimer's disease: the way forward. Drugs 1997, 53:752-768.
43. Hansson L, Lithell H, Skoog I., et al.: Study on Cognition and Prognosis in the Elderly (SCOPE). Blood Press 1999, 8:177-183.